Global Artificial Pancreas Market Size, Share, Forecast Report, 2020-2027

Artificial pancreas are devices that mimics the glucose regulating function of healthy pancreas. These devices use computer-controlled algorithm so as to precisely calculate the amount of insulin to be delivered by using an insulin infusion pump. Advanced products can deliver bi-hormones so as to avoid excessive fall in blood sugar and more closely mimic the working of healthy pancreas with little or no input from the patient.

Considering all these factors the market for Artificial Pancreas is expected to reach $ 360 million by the end of 2023, this market is projected to growing at a CAGR of ~ 15.2 % during 2017-2023.

Key players of Global Artificial Pancreas Market:

Key players profiled in the report are Medtronic, Johnson & Johnson, Beta Bionics, Bigfoot Biomedical, Admetsys (pipeline product analysis), Animas Corporation, Defymed, dexcom, Insulet, medtech, Medtronic, Semma Therapeutics, Tandem Diabetes Care, TypeZero Technologies, and others.
Segments:

The global artificial pancreas market is segmented on the basis of type and end users.
Based on type, the market has been segmented as threshold suspend device system, non-threshold suspend device system, control-to-range (CTR) system, and control-to-target (CTT) system.
Based on the treatment type, the market has been segmented as insulin only, bi-hormonal, and hybrid.
Based on the end users, the market has been segmented as hospitals and clinics, research, and others.